Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mereo BioPharma (MREO) Shares Issued (2023 - 2025)

Historic Shares Issued for Mereo BioPharma (MREO) over the last 3 years, with Q1 2025 value amounting to $487000.0.

  • Mereo BioPharma's Shares Issued changed N/A to $487000.0 in Q1 2025 from the same period last year, while for Sep 2025 it was $487000.0, marking a year-over-year decrease of 9896.38%. This contributed to the annual value of $47.0 million for FY2024, which is 30499.78% up from last year.
  • Per Mereo BioPharma's latest filing, its Shares Issued stood at $487000.0 for Q1 2025.
  • Over the past 5 years, Mereo BioPharma's Shares Issued peaked at $47.0 million during Q2 2024, and registered a low of $487000.0 during Q1 2025.
  • Its 3-year average for Shares Issued is $19.7 million, with a median of $11.5 million in 2023.